News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Tonix Pharmaceuticals
|
March 9, 2022

Tonix Pharmaceuticals will collaborate with Massachusetts General Hospital to further develop a humanized monoclonal antibody, TNX-1500, to prevent organ transplant rejection, specifically in kidney transplants.

Potential Uses Include: Biomarker of Immunity to SARS-CoV-2; Personalized Approach to Timing COVID-19 Vaccine Boosters; Public Health Surveillance; and Serving as an Endpoint for COVID-19 Vaccine Trials

Montana State University
|
February 26, 2022

Their ideas included a virtual reality textbook, a new building material, a food incubator, a device to assist construction workers, various software solutions and a student-focused professional networking platform.

University of Montana
|
February 26, 2022

As research programs grow at the University of Montana, a team of vaccine scientists are making headway into long-term COVID-19 prevention and clinical trials for an opioid vaccine.

Montana BioScience Alliance
|
February 25, 2022

The Montana BioScience Alliance is pleased to announce that Michelle Hood has been inducted into the 2021 MBA Hall of Fame. Ms. Hood is Executive Vice President and Chief Operating Officer of the American Hospital Association and was instrumental in the formation of the Montana BioScience Alliance.

ARTICLES OF INTEREST

National Institutes of Health
|
March 27, 2023

SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]

FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.

Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology  that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.

Doctors have told health services to prepare for a new era of cancer screening after a study found a simple blood test could spot multiple cancer types in patients before they develop clear symptoms.

It’s been 60 years since President Kennedy delivered his iconic moonshot speech, marking a goal for America to launch a man into space to step foot on the moon, and bring him back to Earth. On Sept. 12, President Biden gave a speech at the Kennedy Presidential Library in Boston, outlining the progress on his own self-described moonshot: ending cancer.

NEWSLETTER

Newsletter
|
February 2, 2023

View the Winter 2022 now!

Newsletter
|
November 30, 2022

View the Fall 2022 now!